FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Charles Koller

Research Profile

Procedures

Disorders

Concepts & Ideas

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Tapan M Kadia; Hagop M Kantarjian; Charles Koller; Sherry Pierce; Gautam Borthakur; Mark Brandt; Zeev Estrov; Stefan Faderl; Guillermo Garcia-Manero; Xuelin Huang; Elias Jabbour; Sergerrne York; Farhad Ravandi
Final results of the phase II study of rabbit anti-thymocyte globulin, ciclosporin, methylprednisone, and granulocyte colony-stimulating factor in patients with aplastic anaemia and myelodysplastic syndrome.
A Megan Cornelison; Charles Koller; Mary Alma Welch; Elias Jabbour
Dasatinib combined with interferon-alfa induces a complete cytogenetic response and major molecular response in a patient with chronic myelogenous leukemia harboring the T315I BCR-ABL1 mutation.
Jorge Cortes; Alfonso Quintás-Cardama; Dan Jones; Farhad Ravandi; Guillermo Garcia-Manero; Srdan Verstovsek; Charles Koller; Jody Hiteshew; Jenny Shan; Susan O'Brien; Hagop Kantarjian
Immune modulation of minimal residual disease in early chronic phase chronic myelogenous leukemia: a randomized trial of frontline high-dose imatinib mesylate with or without pegylated interferon alpha-2b and granulocyte-macrophage colony-stimulating factor.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Charles Koller (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Tapan M Kadia; Hagop M Kantarjian; Charles Koller; Sherry Pierce; Gautam Borthakur; Mark Brandt; Zeev Estrov; Stefan Faderl; Guillermo Garcia-Manero; Xuelin Huang; Elias Jabbour; Sergerrne York; Farhad Ravandi
Final results of the phase II study of rabbit anti-thymocyte globulin, ciclosporin, methylprednisone, and granulocyte colony-stimulating factor in patients with aplastic anaemia and myelodysplastic syndrome.
British journal of haematology 2012;157(3):312-20.
2011: A Megan Cornelison; Charles Koller; Mary Alma Welch; Elias Jabbour
Dasatinib combined with interferon-alfa induces a complete cytogenetic response and major molecular response in a patient with chronic myelogenous leukemia harboring the T315I BCR-ABL1 mutation.
Clinical lymphoma, myeloma & leukemia 2011;11 Suppl 1():S111-3.
2011: Jorge Cortes; Alfonso Quintás-Cardama; Dan Jones; Farhad Ravandi; Guillermo Garcia-Manero; Srdan Verstovsek; Charles Koller; Jody Hiteshew; Jenny Shan; Susan O'Brien; Hagop Kantarjian
Immune modulation of minimal residual disease in early chronic phase chronic myelogenous leukemia: a randomized trial of frontline high-dose imatinib mesylate with or without pegylated interferon alpha-2b and granulocyte-macrophage colony-stimulating factor.
Cancer 2011;117(3):572-80.
2011: Gloria N Mattiuzzi; Jorge Cortes; Gladys Alvarado; Srdan Verstovsek; Charles Koller; Sherry Pierce; Deborah Blamble; Stefan Faderl; Lianchun Xiao; Mike Hernandez; Hagop Kantarjian
Efficacy and safety of intravenous voriconazole and intravenous itraconazole for antifungal prophylaxis in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2011;19(1):19-26.
2010: Dushyant Verma; Andrew Lamb; Jianqin Shan; Susan O'Brien; Zeev Estrov; Guillermo Garcia-Manero; Charles Koller; Gautam Borthakur; Jorge Cortes
Survival outcomes for clonal evolution in chronic myeloid leukemia patients on second generation tyrosine kinase inhibitor therapy.
Cancer 2010;116(11):2673-81.
2010: Jorge E Cortes; Dan Jones; Susan O'Brien; Elias Jabbour; Farhad Ravandi; Charles Koller; Gautam Borthakur; Brenda Walker; Weiqiang Zhao; Jianqin Shan; Andrew Lamb
Results of dasatinib therapy in patients with early chronic-phase chronic myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(3):398-404.
2010: Ali Al Ameri; Charles Koller; Andrew Lamb; Farhad Ravandi; Srdan Verstovsek; Gautam Borthakur; Sherry Pierce; Gloria N Mattiuzzi
Acute pulmonary failure during remission induction chemotherapy in adults with acute myeloid leukemia or high-risk myelodysplastic syndrome.
Cancer 2010;116(1):93-7.
2009: F P S Santos; Stefan Faderl; Guillermo Garcia-Manero; Charles Koller; Miloslav Beran; Susan O'Brien; Sherry Pierce; Emil J Freireich; Xuelin Huang; Gautam Borthakur; Carlos E Bueso-Ramos; Marcos De Lima; Michael Keating; Jorge Cortes; Andrew Lamb; Farhad Ravandi
Adult acute erythroleukemia: an analysis of 91 patients treated at a single institution.
Leukemia 2009;23(12):2275-80.
2009: Elias Jabbour; Daniel Jones; Hagop M Kantarjian; Susan O'Brien; Constantine Tam; Charles Koller; Jan A Burger; Gautam Borthakur; William G Wierda; Jorge Cortes
Long-term outcome of patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors after imatinib failure is predicted by the in vitro sensitivity of BCR-ABL kinase domain mutations.
Blood 2009;114(10):2037-43.
2009: R Garg; Stefan Faderl; Guillermo Garcia-Manero; Jorge Cortes; Charles Koller; X Huang; S York; Sherry Pierce; M Brandt; Miloslav Beran; Gautam Borthakur; Andrew Lamb; Farhad Ravandi
Phase II study of rabbit anti-thymocyte globulin, cyclosporine and granulocyte colony-stimulating factor in patients with aplastic anemia and myelodysplastic syndrome.
Leukemia 2009;23(7):1297-302.
2009: Jan A Burger; Susan O'Brien; Xuemei Wang; Stefan Faderl; Alessandra Ferrajoli; Kim-Anh Do; Guillermo Garcia-Manero; Jorge Cortes; Deborah Thomas; Charles Koller; Jan Burger; Susan Lerner; Andrew Lamb; Michael Keating
Characteristics associated with important clinical end points in patients with chronic lymphocytic leukemia at initial treatment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(10):1637-43.
2009: Dushyant Verma; Susan O'Brien; Deborah Thomas; Stefan Faderl; Charles Koller; Sherry Pierce; Partow Kebriaei; Guillermo Garcia-Manero; Jorge Cortes; Andrew Lamb; Farhad Ravandi
Therapy-related acute myelogenous leukemia and myelodysplastic syndrome in patients with acute lymphoblastic leukemia treated with the hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimens.
Cancer 2009;115(1):101-6.
2008: Ahmed Aribi; Andrew Lamb; Charles Koller; Deborah Thomas; Stefan Faderl; Guillermo Garcia-Manero; Jorge Cortes
The effect of interleukin 11 on thrombocytopenia associated with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia.
Cancer 2008;113(6):1338-43.
2008: Amar Safdar; Gilhen H Rodriguez; Adriana M Rueda; William G Wierda; Alessandra Ferrajoli; Daniel M Musher; Susan O'Brien; Charles Koller; Gerald P Bodey; Michael J Keating
Multiple-dose granulocyte-macrophage-colony-stimulating factor plus 23-valent polysaccharide pneumococcal vaccine in patients with chronic lymphocytic leukemia: a prospective, randomized trial of safety and immunogenicity.
Cancer 2008;113(2):383-7.
2008: Elias Jabbour; Hagop M Kantarjian; Charles Koller; Ali Taher
Red blood cell transfusions and iron overload in the treatment of patients with myelodysplastic syndromes.
Cancer 2008;112(5):1089-95.
2008: Apostolia-Maria Tsimberidou; Hagop M Kantarjian; Sijin Wen; Susan O'Brien; Jorge Cortes; William G Wierda; Charles Koller; Sherry Pierce; Mark Brandt; Emil J Freireich; Michael J Keating; Elihu H Estey
The prognostic significance of serum beta2 microglobulin levels in acute myeloid leukemia and prognostic scores predicting survival: analysis of 1,180 patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(3):721-30.
2008: Guillermo Garcia-Manero; Hui Yang; Carlos E Bueso-Ramos; Alessandra Ferrajoli; Jorge Cortes; William G Wierda; Stefan Faderl; Charles Koller; Gail Morris; Gary Rosner; Andrey Loboda; Valeria R Fantin; Sophia S Randolph; James S Hardwick; John F Reilly; Cong Chen; Justin L Ricker; J Paul Secrist; Victoria M Richon; Stanley R Frankel; Hagop M Kantarjian
Phase 1 study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid [SAHA]) in patients with advanced leukemias and myelodysplastic syndromes.
Blood 2008;111(3):1060-6.
2007: Jorge Cortes; Elias Jabbour; George Q Daley; Susan O'Brien; Srdan Verstovsek; Alessandra Ferrajoli; Charles Koller; Yali Zhu; Paul Statkevich; Andrew Lamb
Phase 1 study of lonafarnib (SCH 66336) and imatinib mesylate in patients with chronic myeloid leukemia who have failed prior single-agent therapy with imatinib.
Cancer 2007;110(6):1295-302.
2007: William G Wierda; Susan O'Brien; Xuemei Wang; Stefan Faderl; Alessandra Ferrajoli; Kim-Anh Do; Jorge Cortes; Deborah Thomas; Guillermo Garcia-Manero; Charles Koller; Miloslav Beran; Francis Giles; Farhad Ravandi; Susan Lerner; Andrew Lamb; Michael Keating
Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemia.
Blood 2007;109(11):4679-85.
2007: Ahmed Aribi; Hagop M Kantarjian; Elihu H Estey; Charles Koller; Deborah A Thomas; Steven M Kornblau; Stefan Faderl; Nakia M Laddie; Guillermo Garcia-Manero; Jorge E Cortes
Combination therapy with arsenic trioxide, all-trans retinoic acid, and gemtuzumab ozogamicin in recurrent acute promyelocytic leukemia.
Cancer 2007;109(7):1355-9.
2006: Guillermo Garcia-Manero; Hagop M Kantarjian; Blanca Sanchez-Gonzalez; Hui Yang; Gary Rosner; Srdan Verstovsek; Michael Rytting; William G Wierda; Farhad Ravandi; Charles Koller; Lianchun Xiao; Stefan Faderl; Zeev Estrov; Jorge Cortes; Susan O'Brien; Elihu Estey; Carlos E Bueso-Ramos; Jackie Fiorentino; Elias Jabbour; Jean-Pierre J Issa
Phase 1/2 study of the combination of 5-aza-2'-deoxycytidine with valproic acid in patients with leukemia.
Blood 2006;108(10):3271-9.
2006: Apostolia-Maria Tsimberidou; Susan O'Brien; Hagop M Kantarjian; Charles Koller; Fredrick B Hagemeister; Luis Fayad; Susan Lerner; Carlos E Bueso-Ramos; Michael J Keating
Hodgkin transformation of chronic lymphocytic leukemia: the M. D. Anderson Cancer Center experience.
Cancer 2006;107(6):1294-302.
2006: Charles Koller; B Nebiyou Bekele; Xian Zhou; Charles Park; Zeev Estrov; Susan O'Brien; Michael Keating; Iman Jilani; Francis Giles; Hagop M Kantarjian; Maher Albitar
Plasma thrombopoietin compared with immunoglobulin heavy-chain mutation status as a predictor of survival in chronic lymphocytic leukemia.
Blood 2006;108(3):1001-6.
2006: Stefan Faderl; Srdan Verstovsek; Jorge Cortes; Farhad Ravandi; Miloslav Beran; Guillermo Garcia-Manero; Alessandra Ferrajoli; Zeev Estrov; Susan O'Brien; Charles Koller; Francis Giles; William G Wierda; Monica Kwari; Hagop M Kantarjian
Clofarabine and cytarabine combination as induction therapy for acute myeloid leukemia (AML) in patients 50 years of age or older.
Blood 2006;108(1):45-51.
2006: Farhad Ravandi; Jeffrey L Jorgensen; Susan M O'Brien; Srdan Verstovsek; Charles Koller; Stefan Faderl; Francis Giles; Alessandra Ferrajoli; William G Wierda; Shirley Odinga; Xuelin Huang; Deborah A Thomas; Emil J Freireich; Dan Jones; Michael J Keating; Hagop M Kantarjian
Eradication of minimal residual disease in hairy cell leukemia.
Blood 2006;107(12):4658-62.
2006: Patricia Ault; Andrew Lamb; Susan O'Brien; Stefan Faderl; Miloslav Beran; Mary Beth Rios; Charles Koller; Francis Giles; Michael Keating; Moshe Talpaz; Jorge Cortes
Pregnancy among patients with chronic myeloid leukemia treated with imatinib.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(7):1204-8.
2006: Yasuhiro Oki; Hagop M Kantarjian; Xian Zhou; Jorge Cortes; Stefan Faderl; Srdan Verstovsek; Susan O'Brien; Charles Koller; Miloslav Beran; B Nebiyou Bekele; Sherry Pierce; Deborah Thomas; Farhad Ravandi; William G Wierda; Francis Giles; Alessandra Ferrajoli; Elias Jabbour; Michael J Keating; Carlos E Bueso-Ramos; Elihu Estey; Guillermo Garcia-Manero
Adult acute megakaryocytic leukemia: an analysis of 37 patients treated at M.D. Anderson Cancer Center.
Blood 2006;107(3):880-4.
2005: Farhad Ravandi; Susan O'Brien; Dan Jones; Susan Lerner; Stefan Faderl; Alessandra Ferrajoli; William G Wierda; Guillermo Garcia-Manero; Deborah Thomas; Charles Koller; Srdan Verstovsek; Francis Giles; Jorge Cortes; Marco Herling; Andrew Lamb; Michael Keating
T-cell prolymphocytic leukemia: a single-institution experience.
Clinical lymphoma & myeloma 2005;6(3):234-9.
2005: Michael J Keating; Susan O'Brien; Maher Albitar; Susan Lerner; William Plunkett; Francis Giles; Michael Andreeff; Jorge Cortes; Stefan Faderl; Deborah Thomas; Charles Koller; William G Wierda; Michelle A Detry; Alice Lynn; Andrew Lamb
Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(18):4079-88.
2005: William G Wierda; Susan O'Brien; Sijin Wen; Stefan Faderl; Guillermo Garcia-Manero; Deborah Thomas; Kim-Anh Do; Jorge Cortes; Charles Koller; Miloslav Beran; Alessandra Ferrajoli; Francis Giles; Susan Lerner; Maher Albitar; Andrew Lamb; Michael Keating
Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab for relapsed and refractory chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(18):4070-8.
2005: Jorge Cortes; Stefan Faderl; Elihu Estey; Razelle Kurzrock; Deborah Thomas; Miloslav Beran; Guillermo Garcia-Manero; Alessandra Ferrajoli; Francis Giles; Charles Koller; Susan O'Brien; John Wright; Stephen A Bai; Andrew Lamb
Phase I study of BMS-214662, a farnesyl transferase inhibitor in patients with acute leukemias and high-risk myelodysplastic syndromes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(12):2805-12.
2004: Andrew Lamb; Deborah Thomas; Susan O'Brien; Jorge Cortes; Francis Giles; Sima Jeha; Carlos E Bueso-Ramos; Sherry Pierce; Jianqin Shan; Charles Koller; Miloslav Beran; Michael Keating; Emil J Freireich
Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia.
Cancer 2004;101(12):2788-801.
2004: Deborah A Thomas; Susan O'Brien; Jorge Cortes; Francis Giles; Stefan Faderl; Srdan Verstovsek; Alessandra Ferrajoli; Charles Koller; Miloslav Beran; Sherry Pierce; Chul Ha; Fernando Cabanillas; Michael J Keating; Andrew Lamb
Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma.
Blood 2004;104(6):1624-30.
2004: Jorge Cortes; Deborah Thomas; Charles Koller; Francis Giles; Elihu Estey; Stefan Faderl; Guillermo Garcia-Manero; David J McConkey; Stacey Ruiz; Gira Patel; Roberto Guerciolini; John Wright; Andrew Lamb
Phase I study of bortezomib in refractory or relapsed acute leukemias.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(10):3371-6.
2004: Kevin E Sanders; Chul Ha; Jorge E Cortes-Franco; Charles Koller; Hagop M Kantarjian; James D Cox
The role of craniospinal irradiation in adults with a central nervous system recurrence of leukemia.
Cancer 2004;100(10):2176-80.
2004: Francis Giles; Deborah Thomas; Guillermo Garcia-Manero; Stefan Faderl; Jorge Cortes; Srdan Verstovsek; Alessandra Ferrajoli; Sima Jeha; Miloslav Beran; Charles Koller; Michael Andreeff; Ann Cahill; Caroline Clairmont; Mario Sznol; Andrew Lamb
A Phase I and pharmacokinetic study of VNP40101M, a novel sulfonylhydrazine alkylating agent, in patients with refractory leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(9):2908-17.
2003: Susan M O'Brien; Hagop M Kantarjian; Deborah A Thomas; Jorge Cortes; Francis Giles; William G Wierda; Charles Koller; Alessandra Ferrajoli; Mary L Browning; Susan Lerner; Maher Albitar; Michael J Keating
Alemtuzumab as treatment for residual disease after chemotherapy in patients with chronic lymphocytic leukemia.
Cancer 2003;98(12):2657-63.
2003: Jorge Cortes; Patricia Ault; Charles Koller; Deborah Thomas; Alessandra Ferrajoli; William G Wierda; Mary Beth Rios; Laurie Letvak; Elizabeth S Kaled; Andrew Lamb
Efficacy of imatinib mesylate in the treatment of idiopathic hypereosinophilic syndrome.
Blood 2003;101(12):4714-6.
2003: Stefan Faderl; Deborah A Thomas; Susan O'Brien; Guillermo Garcia-Manero; Hagop M Kantarjian; Francis Giles; Charles Koller; Alessandra Ferrajoli; Srdan Verstovsek; Barbara Pro; Michael Andreeff; Miloslav Beran; Jorge Cortes; William G Wierda; Ngoc Tran; Michael J Keating
Experience with alemtuzumab plus rituximab in patients with relapsed and refractory lymphoid malignancies.
Blood 2003;101(9):3413-5.
2003: Francis Giles; Stefan Faderl; Deborah A Thomas; Jorge E Cortes; Guillermo Garcia-Manero; Dan Douer; Alexandra M Levine; Charles Koller; Sima Jeha; Susan M O'Brien; Elihu H Estey; Hagop M Kantarjian
Randomized phase I/II study of troxacitabine combined with cytarabine, idarubicin, or topotecan in patients with refractory myeloid leukemias.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(6):1050-6.
2003: Jorge Cortes; Andrew Lamb; Maher Albitar; Deborah Thomas; Stefan Faderl; Charles Koller; Guillermo Garcia-Manero; Francis Giles; Michael Andreeff; Susan O'Brien; Michael Keating; Elihu Estey
A randomized trial of liposomal daunorubicin and cytarabine versus liposomal daunorubicin and topotecan with or without thalidomide as initial therapy for patients with poor prognosis acute myelogenous leukemia or myelodysplastic syndrome.
Cancer 2003;97(5):1234-41.
2003: Jorge Cortes; Maher Albitar; Deborah Thomas; Francis Giles; Razelle Kurzrock; Alain Thibault; Wayne Rackoff; Charles Koller; Susan O'Brien; Guillermo Garcia-Manero; Moshe Talpaz; Andrew Lamb
Efficacy of the farnesyl transferase inhibitor R115777 in chronic myeloid leukemia and other hematologic malignancies.
Blood 2003;101(5):1692-7.
2002: Michael J Keating; Susan O'Brien; Dimitrios P Kontoyiannis; William Plunkett; Charles Koller; Miloslav Beran; Susan Lerner; Andrew Lamb
Results of first salvage therapy for patients refractory to a fludarabine regimen in chronic lymphocytic leukemia.
Leukemia & lymphoma 2002;43(9):1755-62.
2002: Patricia Ault; Jorge Cortes; Charles Koller; Elizabeth S Kaled; Andrew Lamb
Response of idiopathic hypereosinophilic syndrome to treatment with imatinib mesylate.
Leukemia research 2002;26(9):881-4.
2002: Alessandra Ferrajoli; Michael J Keating; Taghi Manshouri; Francis Giles; Amanda Dey; Zeev Estrov; Charles Koller; Razelle Kurzrock; Deborah A Thomas; Stefan Faderl; Susan Lerner; Susan O'Brien; Maher Albitar
The clinical significance of tumor necrosis factor-alpha plasma level in patients having chronic lymphocytic leukemia.
Blood 2002;100(4):1215-9.
2002: Hagop M Kantarjian; Moshe Talpaz; Susan O'Brien; Terry L Smith; Francis Giles; Stefan Faderl; Deborah A Thomas; Guillermo Garcia-Manero; Jean-Pierre J Issa; Michael Andreeff; Steven M Kornblau; Charles Koller; Miloslav Beran; Michael Keating; Mary Beth Rios; Jianqin Shan; Debra Resta; Renaud Capdeville; Kimberly Hayes; Maher Albitar; Emil J Freireich; Jorge E Cortes
Imatinib mesylate for Philadelphia chromosome-positive, chronic-phase myeloid leukemia after failure of interferon-alpha: follow-up results.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(7):2177-87.
2002: Susan O'Brien; Moshe Talpaz; Jorge Cortes; Jianqin Shan; Francis Giles; Stefan Faderl; Deborah Thomas; Guillermo Garcia-Manero; Susie Mallard; Mary Beth; Charles Koller; Steven M Kornblau; Michael Andreeff; Anthony J Murgo; Michael Keating; Hagop M Kantarjian
Simultaneous homoharringtonine and interferon-alpha in the treatment of patients with chronic-phase chronic myelogenous leukemia.
Cancer 2002;94(7):2024-32.
2002: Jorge Cortes; Deborah Thomas; Adan Rios; Charles Koller; Susan O'Brien; Sima Jeha; Stefan Faderl; Andrew Lamb
Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma/leukemia.
Cancer 2002;94(5):1492-9.
2002: Usha R Surapaneni; Jorge E Cortes; Deborah Thomas; Susan O'Brien; Francis Giles; Charles Koller; Stefan Faderl; Andrew Lamb
Central nervous system relapse in adults with acute lymphoblastic leukemia.
Cancer 2002;94(3):773-9.
2001: Jorge Cortes; Susan O'Brien; J Loscertales; Andrew Lamb; Francis Giles; Deborah Thomas; Charles Koller; Michael Keating
Cyclosporin A for the treatment of cytopenia associated with chronic lymphocytic leukemia.
Cancer 2001;92(8):2016-22.
2001: Miloslav Beran; Yu Shen; Andrew Lamb; Susan O'Brien; Charles Koller; Francis Giles; Jorge Cortes; Deborah A Thomas; Stefan Faderl; Simona Despa; Elihu H Estey
High-dose chemotherapy in high-risk myelodysplastic syndrome: covariate-adjusted comparison of five regimens.
Cancer 2001;92(8):1999-2015.
2001: R Aboul-Nasr; Susan O'Brien; Emil J Freireich; C F Ginsberg; Hagop M Kantarjian; Charles Koller; Michael J Keating; Maher Albitar
"T-cell-rich B-cell lymphoproliferative disorder" of the bone marrow.
Leukemia & lymphoma 2001;42(5):1023-31.
2001: Srdan Verstovsek; Andrew Lamb; Elihu Estey; Alvaro Aguayo; Francis Giles; Taghi Manshouri; Charles Koller; Zeev Estrov; Emil J Freireich; Michael Keating; Maher Albitar
Plasma hepatocyte growth factor is a prognostic factor in patients with acute myeloid leukemia but not in patients with myelodysplastic syndrome.
Leukemia 2001;15(8):1165-70.
2001: Elihu Estey; Charles Koller; Jorge Cortes; P Reed; Emil J Freireich; Francis Giles; Andrew Lamb
Treatment of newly-diagnosed acute promyelocytic leukemia with liposomal all-trans retinoic acid.
Leukemia & lymphoma 2001;42(3):309-16.
2001: Jorge Cortes; Elihu Estey; Susan O'Brien; Francis Giles; Yu Shen; Charles Koller; Miloslav Beran; Deborah Thomas; Michael Keating; Andrew Lamb
High-dose liposomal daunorubicin and high-dose cytarabine combination in patients with refractory or relapsed acute myelogenous leukemia.
Cancer 2001;92(1):7-14.
2001: Alvaro Aguayo; Taghi Manshouri; Susan O'Brien; Michael Keating; Miloslav Beran; Charles Koller; Andrew Lamb; Anna Rogers; Maher Albitar
Clinical relevance of Flt1 and Tie1 angiogenesis receptors expression in B-cell chronic lymphocytic leukemia (CLL).
Leukemia research 2001;25(4):279-85.
2001: Susan M O'Brien; Hagop M Kantarjian; Jorge Cortes; Miloslav Beran; Charles Koller; Francis Giles; Susan Lerner; Michael Keating
Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(5):1414-20.
2000: Alvaro Aguayo; Andrew Lamb; Taghi Manshouri; Christy Gidel; Elihu Estey; Deborah Thomas; Charles Koller; Zeev Estrov; Susan O'Brien; Michael Keating; Emil J Freireich; Maher Albitar
Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes.
Blood 2000;96(6):2240-5.
2000: Alvaro Aguayo; Susan O'Brien; Michael Keating; Taghi Manshouri; Christy Gidel; Bart Barlogie; Miloslav Beran; Charles Koller; Andrew Lamb; Maher Albitar
Clinical relevance of intracellular vascular endothelial growth factor levels in B-cell chronic lymphocytic leukemia.
Blood 2000;96(2):768-70.
2000: Jorge Cortes; Elihu Estey; Miloslav Beran; Susan O'Brien; Francis Giles; Charles Koller; Michael Keating; Andrew Lamb
Cyclophosphamide, ara-C and topotecan (CAT) for patients with refractory or relapsed acute leukemia.
Leukemia & lymphoma 2000;36(5-6):479-84.
2000: Hagop M Kantarjian; Susan O'Brien; Terry L Smith; Jorge Cortes; Francis Giles; Miloslav Beran; Sherry Pierce; Yang Huh; Michael Andreeff; Charles Koller; Chul Ha; Michael J Keating; S Murphy; Emil J Freireich
Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(3):547-61.
1999: S Sacchi; Hagop M Kantarjian; Susan O'Brien; Jorge Cortes; Mary Beth Rios; Francis Giles; Miloslav Beran; Charles Koller; Michael J Keating; Moshe Talpaz
Chronic myelogenous leukemia in nonlymphoid blastic phase: analysis of the results of first salvage therapy with three different treatment approaches for 162 patients.
Cancer 1999;86(12):2632-41.
1999: Charles Koller; Hagop M Kantarjian; Eric J Feldman; Susan O'Brien; Mary Beth Rios; Elihu Estey; Michael Keating
A phase I-II trial of escalating doses of mitoxantrone with fixed doses of cytarabine plus fludarabine as salvage therapy for patients with acute leukemia and the blastic phase of chronic myelogenous leukemia.
Cancer 1999;86(11):2246-51.
1999: S Sacchi; Hagop M Kantarjian; E J Freireich; Susan O'Brien; Jorge Cortes; Mary Beth Rios; S Kornblau; Francis Giles; Charles Koller; James L Gajewski; Moshe Talpaz
Unexpected high incidence of severe toxicities associated with alpha interferon, low-dose cytosine arabinoside and all-trans retinoic acid in patients with chronic myelogenous leukemia.
Leukemia & lymphoma 1999;35(5-6):483-9.
1999: Deborah A Thomas; Andrew Lamb; Terry L Smith; Charles Koller; Jorge Cortes; Susan O'Brien; Francis Giles; James L Gajewski; Sherry Pierce; Michael J Keating
Primary refractory and relapsed adult acute lymphoblastic leukemia: characteristics, treatment results, and prognosis with salvage therapy.
Cancer 1999;86(7):1216-30.
1999: Miloslav Beran; Elihu Estey; Susan O'Brien; Jorge Cortes; Charles Koller; Francis Giles; Steven M Kornblau; Michael Andreeff; Norbert Vey; S R Pierce; Kimberly Hayes; G C Wong; Michael Keating; Andrew Lamb
Topotecan and cytarabine is an active combination regimen in myelodysplastic syndromes and chronic myelomonocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(9):2819-30.
1999: Susan O'Brien; Andrew Lamb; Charles Koller; E Feldman; Miloslav Beran; Michael Andreeff; Sergio Giralt; B Cheson; Michael Keating; Emil J Freireich; Mary Beth Rios; Moshe Talpaz
Sequential homoharringtonine and interferon-alpha in the treatment of early chronic phase chronic myelogenous leukemia.
Blood 1999;93(12):4149-53.
1999: Chul Ha; W K Chung; Charles Koller; James D Cox
Role of radiation therapy to the brain in leukemic patients with cranial nerve palsies in the absence of radiological findings.
Leukemia & lymphoma 1999;32(5-6):497-503.
1999: Norbert Vey; Andrew Lamb; Miloslav Beran; Susan O'Brien; Jorge Cortes; Charles Koller; Elihu Estey
Combination of topotecan with cytarabine or etoposide in patients with refractory or relapsed acute myeloid leukemia: results of a randomized phase I/II study.
Investigational new drugs 1999;17(1):89-95.
1999: Hagop M Kantarjian; Susan O'Brien; Terry L Smith; Mary Beth Rios; Jorge Cortes; Miloslav Beran; Charles Koller; Francis Giles; Michael Andreeff; Steven M Kornblau; Sergio Giralt; Michael J Keating; Moshe Talpaz
Treatment of Philadelphia chromosome-positive early chronic phase chronic myelogenous leukemia with daily doses of interferon alpha and low-dose cytarabine.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(1):284-92.
1999: C M Anderson; Carlos E Bueso-Ramos; S A Wallner; Maher Albitar; T E Rosenzweig; Charles Koller
Primary myeloid leukemia presenting concomitantly with primary multiple myeloma: two cases and an update of the literature.
Leukemia & lymphoma 1999;32(3-4):385-90.
1998: Miloslav Beran; Elihu Estey; Susan M O'Brien; Francis Giles; Charles Koller; Steven M Kornblau; Michael Keating; Hagop M Kantarjian
Results of topotecan single-agent therapy in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia.
Leukemia & lymphoma 1998;31(5-6):521-31.
1998: Michael J Keating; Susan O'Brien; Susan Lerner; Charles Koller; Miloslav Beran; LE Robertson; Emil J Freireich; Elihu Estey; Andrew Lamb
Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy.
Blood 1998;92(4):1165-71.
1998: Steven M Kornblau; Michael Andreeff; Shi-Xue Hu; Hong-Ji Xu; Shreyaskumar Patel; A Theriault; Charles Koller; Andrew Lamb; Elihu Estey; Albert Deisseroth; William F Benedict
Low and maximally phosphorylated levels of the retinoblastoma protein confer poor prognosis in newly diagnosed acute myelogenous leukemia: a prospective study.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(8):1955-63.
1998: Steven M Kornblau; Andrew Lamb; Susan O'Brien; Michael Andreeff; Charles Koller; Miloslav Beran; Michael Keating; Elihu Estey
CECA-cyclophosphamide, etoposide, carboplatin and cytosine arabinoside--a new salvage regimen for relapsed or refractory acute myelogenous leukemia.
Leukemia & lymphoma 1998;28(3-4):371-5.
1997: Charles Koller; Hagop M Kantarjian; Deborah Thomas; Susan O'Brien; Mary Beth Rios; Steven M Kornblau; S Murphy; Michael Keating
The hyper-CVAD regimen improves outcome in relapsed acute lymphoblastic leukemia.
Leukemia 1997;11(12):2039-44.
1997: Susan O'Brien; Andrew Lamb; Miloslav Beran; Charles Koller; Moshe Talpaz; Susan Lerner; Michael J Keating
Fludarabine and granulocyte colony-stimulating factor (G-CSF) in patients with chronic lymphocytic leukemia.
Leukemia 1997;11(10):1631-5.
1997: S Sacchi; Hagop M Kantarjian; Susan O'Brien; Miloslav Beran; Charles Koller; Sherry Pierce; S Kornblau; E Estey; Michael J Keating; Moshe Talpaz
Long-term follow-up results of alpha-interferon-based regimens in patients with late chronic phase chronic myelogenous leukemia.
Leukemia 1997;11(10):1610-6.
1997: A W Bseiso; Hagop M Kantarjian; Jie Qiang Guo; Jorge Cortes; Moshe Talpaz; Charles Koller; Maher Albitar; Michael Keating; Ralph B Arlinghaus
Analysis of the BCR-ABL protein in Philadelphia chromosome-positive adult acute lymphocytic leukemia.
Leukemia 1997;11(9):1583-7.
1997: Sergio Giralt; Elihu Estey; Maher Albitar; Koen van Besien; Gabriela Rondón; Paolo Anderlini; Susan O'Brien; Issa Khouri; James L Gajewski; RC Mehra; David F Claxton; Borje Andersson; Miloslav Beran; Donna Przepiorka; Charles Koller; Steven M Kornblau; M Kørbling; Michael Keating; Andrew Lamb; Richard Champlin
Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy.
Blood 1997;89(12):4531-6.
1996: Steven M Kornblau; Varsha Gandhi; H M Andreeff; Miloslav Beran; Hagop M Kantarjian; Charles Koller; Susan O'Brien; William Plunkett; Elihu Estey
Clinical and laboratory studies of 2-chlorodeoxyadenosine +/- cytosine arabinoside for relapsed or refractory acute myelogenous leukemia in adults.
Leukemia 1996;10(10):1563-9.
1996: Miloslav Beran; Andrew Lamb; Susan O'Brien; Charles Koller; M al-Bitar; S Arbuck; Sherry Pierce; M Moore; James L Abbruzzese; Michael Andreeff; Michael Keating; Elihu Estey
Topotecan, a topoisomerase I inhibitor, is active in the treatment of myelodysplastic syndrome and chronic myelomonocytic leukemia.
Blood 1996;88(7):2473-9.
1996: Zeev Estrov; Moshe Talpaz; S Ku; David Harris; Ruth Lapushin; Charles Koller; C Hirsh-Ginsberg; Y Huh; G Yee; Razelle Kurzrock
Molecular and biologic characterization of a newly established Philadelphia-positive acute lymphoblastic leukemia cell line (Z-33) with an autocrine response to GM-CSF.
Leukemia 1996;10(9):1534-43.
1996: Andreas H Sarris; J Cortes; Andrew Lamb; Sherry Pierce; T Smith; Michael Keating; Charles Koller; Steven M Kornblau; Susan O'Brien; Michael Andreeff
Disseminated intravascular coagulation in adult acute lymphoblastic leukemia: frequent complications with fibrinogen levels less than 100 mg/dl.
Leukemia & lymphoma 1996;21(1-2):85-92.
1995: Susan O'Brien; Andrew Lamb; Michael Keating; Miloslav Beran; Charles Koller; LE Robertson; Jeane Hester; Mary Beth Rios; Michael Andreeff; Moshe Talpaz
Homoharringtonine therapy induces responses in patients with chronic myelogenous leukemia in late chronic phase.
Blood 1995;86(9):3322-6.
1995: LE Robertson; Susan O'Brien; Andrew Lamb; Charles Koller; Miloslav Beran; Michael Andreeff; Susan Lerner; William Plunkett; Michael J Keating
A 3-day schedule of fludarabine in previously treated chronic lymphocytic leukemia.
Leukemia 1995;9(9):1444-9.
1995: Susan O'Brien; Andrew Lamb; Miloslav Beran; LE Robertson; Charles Koller; Susan Lerner; Michael J Keating
Interferon maintenance therapy for patients with chronic lymphocytic leukemia in remission after fludarabine therapy.
Blood 1995;86(4):1298-300.
1995: LE Robertson; Susan O'Brien; Andrew Lamb; Charles Koller; Miloslav Beran; Michael Andreeff; Susan Lerner; Michael J Keating
Fludarabine plus doxorubicin in previously treated chronic lymphocytic leukemia.
Leukemia 1995;9(6):943-5.
1995: V Kohli; Charles Koller
Simultaneous detection of type A and type B PML/retinoic acid receptor alpha fusion transcripts in acute promyelocytic leukemia.
Blood 1995;85(3):854-5.
1994: LE Robertson; Elihu Estey; Andrew Lamb; Charles Koller; Susan O'Brien; B Brown; Michael J Keating
Therapy-related leukemia and myelodysplastic syndrome in chronic lymphocytic leukemia.
Leukemia 1994;8(12):2047-51.
1994: J E Cortes; Andrew Lamb; Susan O'Brien; LE Robertson; Charles Koller; C Hirsh-Ginsberg; Sanford A Stass; Michael Keating; Elihu Estey
All-trans retinoic acid followed by chemotherapy for salvage of refractory or relapsed acute promyelocytic leukemia.
Cancer 1994;73(12):2946-52.
1994: Elihu Estey; Peter F Thall; Michael Andreeff; Miloslav Beran; Andrew Lamb; Susan O'Brien; S Escudier; LE Robertson; Charles Koller; Steven M Kornblau
Use of granulocyte colony-stimulating factor before, during, and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: comparison with fludarabine plus cytarabine without granulocyte colony-stimulating factor.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(4):671-8.
1994: Susan O'Brien; Andrew Lamb; Elihu Estey; Charles Koller; B Robertson; Miloslav Beran; Michael Andreeff; Sherry Pierce; Michael Keating
Lack of effect of 2-chlorodeoxyadenosine therapy in patients with chronic lymphocytic leukemia refractory to fludarabine therapy.
The New England journal of medicine 1994;330(5):319-22.
1994: Charles Koller; C C Gorski; Robert S Benjamin; Sewa S Legha; Nicholas E Papadopoulos; Carl Plager
A phase I trial of weekly lomustine in patients with advanced cancer.
Cancer 1994;73(1):236-9.
1993: Susan O'Brien; Andrew Lamb; Miloslav Beran; T Smith; Charles Koller; Elihu Estey; LE Robertson; Susan Lerner; Michael Keating
Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment.
Blood 1993;82(6):1695-700.
1993: Gerald P Bodey; Linda S Elting; J Narro; Charles Koller; S O'Brien; E Estey; R Benjamin
An open trial of cefoperazone plus sulbactam for the treatment of fever in cancer patients.
The Journal of antimicrobial chemotherapy 1993;32(1):141-52.
1993: Charles Koller; V Kohli
Purification of genomic DNA using heparin to remove nuclear proteins.
Nucleic acids research 1993;21(12):2952.
1993: Michael J Keating; Susan O'Brien; Andrew Lamb; William Plunkett; Elihu Estey; Charles Koller; Miloslav Beran; Emil J Freireich
Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agent.
Blood 1993;81(11):2878-84.
1993: A Kemena; Susan O'Brien; Andrew Lamb; L Robertson; Charles Koller; Miloslav Beran; Elihu Estey; William Plunkett; Susan Lerner; Michael J Keating
Phase II clinical trial of fludarabine in chronic lymphocytic leukemia on a weekly low-dose schedule.
Leukemia & lymphoma 1993;10(3):187-93.
1993: Hagop M Kantarjian; Miloslav Beran; A Ellis; Leonard A Zwelling; Susan O'Brien; L Cazenave; Charles Koller; Mary Beth Rios; William Plunkett; Michael J Keating
Phase I study of Topotecan, a new topoisomerase I inhibitor, in patients with refractory or relapsed acute leukemia.
Blood 1993;81(5):1146-51.
1993: Michael J Keating; Susan O'Brien; Andrew Lamb; L B Robertson; Charles Koller; Miloslav Beran; Elihu Estey
Nucleoside analogs in treatment of chronic lymphocytic leukemia.
Leukemia & lymphoma 1993;10 Suppl():139-45.
1993: Elihu Estey; Sherry Pierce; Andrew Lamb; Susan O'Brien; Miloslav Beran; Michael Andreeff; S Escudier; Charles Koller; Steven M Kornblau; L Robertson
Treatment of myelodysplastic syndromes with AML-type chemotherapy.
Leukemia & lymphoma 1993;11 Suppl 2():59-63.
1992: K Fang; Charles Koller; N Brown; W Covington; J R Lin; Dah H Ho
Determination of plicamycin in plasma by radioimmunoassay.
Therapeutic drug monitoring 1992;14(3):255-60.
1992: Elihu Estey; Peter F Thall; Andrew Lamb; Susan O'Brien; Charles Koller; Miloslav Beran; Jordan U Gutterman; Albert Deisseroth; Michael Keating
Treatment of newly diagnosed acute myelogenous leukemia with granulocyte-macrophage colony-stimulating factor (GM-CSF) before and during continuous-infusion high-dose ara-C + daunorubicin: comparison to patients treated without GM-CSF.
Blood 1992;79(9):2246-55.
1992: Hagop M Kantarjian; Michael J Keating; Elihu H Estey; Susan O'Brien; Sherry Pierce; Miloslav Beran; Charles Koller; E Feldman; Moshe Talpaz
Treatment of advanced stages of Philadelphia chromosome-positive chronic myelogenous leukemia with interferon-alpha and low-dose cytarabine.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(5):772-8.
1992: Elihu H Estey; Razelle Kurzrock; Hagop M Kantarjian; Susan M O'Brien; K B McCredie; Miloslav Beran; Charles Koller; Michael J Keating; Cheryl Hirsch-Ginsberg; Y O Huh
Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA).
Blood 1992;79(4):882-7.
1992: Michael J Keating; Elihu Estey; Andrew Lamb; William Plunkett; Susan O'Brien; Charles Koller; Miloslav Beran; Emil J Freireich
Evolution of treatment for acute myelogenous leukemia and myelodysplastic syndrome at M.D. Anderson Cancer Center 1985-1991.
Leukemia 1992;6 Suppl 2():78-80.
1991: Susan O'Brien; Andrew Lamb; Elihu Estey; Charles Koller; Miloslav Beran; K McCredie; Michael Keating
Mitoxantrone and high-dose etoposide for patients with relapsed or refractory acute leukemia.
Cancer 1991;68(4):691-4.
1991: Gerald P Bodey; A Reuben; Linda S Elting; H Kantarjian; M Keating; F Hagemeister; Charles Koller; W Velasquez; N Papadopoulos
Comparison of two schedules of cefoperazone plus aztreonam in the treatment of neutropenic patients with fever.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1991;10(7):551-8.
1991: Razelle Kurzrock; Moshe Talpaz; J A Gomez; Elihu H Estey; Susan O'Brien; Cheryl Hirsch-Ginsberg; Charles Koller; Emil J Freireich; Jordan U Gutterman
Differential dose-related haematological effects of GM-CSF in pancytopenia: evidence supporting the advantage of low- over high-dose administration in selected patients.
British journal of haematology 1991;78(3):352-8.
1991: Hagop M Kantarjian; C Childs; Susan O'Brien; Y Huh; Miloslav Beran; J Schachner; Charles Koller; Michael J Keating
Efficacy of fludarabine, a new adenine nucleoside analogue, in patients with prolymphocytic leukemia and the prolymphocytoid variant of chronic lymphocytic leukemia.
The American journal of medicine 1991;90(2):223-8.
1991: Michael J Keating; Andrew Lamb; Susan O'Brien; Charles Koller; Moshe Talpaz; J Schachner; C C Childs; Emil J Freireich; K B McCredie
Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(1):44-9.
1990: Hagop M Kantarjian; Raymond Alexanian; Charles Koller; Razelle Kurzrock; Michael J Keating
Fludarabine therapy in macroglobulinemic lymphoma.
Blood 1990;75(10):1928-31.
1990: Saroj Vadhan-Raj; W S Velasquez; J J Butler; A LeMaistre; J Lepe-Zuniga; Michael J Keating; Charles Koller; Jordan U Gutterman
Stimulation of myelopoiesis in chronic lymphocytic leukemia and in other lymphoproliferative disorders by recombinant human granulocyte-macrophage colony-stimulating factor.
American journal of hematology 1990;33(3):189-97.
1989: Michael J Keating; Andrew Lamb; Moshe Talpaz; J Redman; Charles Koller; Bart Barlogie; W Velasquez; William Plunkett; Emil J Freireich; K B McCredie
Fludarabine: a new agent with major activity against chronic lymphocytic leukemia.
Blood 1989;74(1):19-25.
1989: Hagop M Kantarjian; Michael J Keating; Ronald S Walters; Charles Koller; K B McCredie; Emil J Freireich
Phase II study of low-dose continuous infusion homoharringtonine in refractory acute myelogenous leukemia.
Cancer 1989;63(5):813-7.
1988: Walter N Hittelman; P Agbor; I Petkovic; Borje Andersson; Andrew Lamb; R Walters; Charles Koller; Miloslav Beran
Detection of leukemic clone maturation in vivo by premature chromosome condensation.
Blood 1988;72(6):1950-60.
1987: Razelle Kurzrock; M Shtalrid; Jordan U Gutterman; Charles Koller; R Walters; J M Trujillo; Moshe Talpaz
Molecular analysis of chromosome 22 breakpoints in adult Philadelphia-positive acute lymphoblastic leukaemia.
British journal of haematology 1987;67(1):55-9.